EC approval for post-steroid graft-versus-host treatment
Jakavi treats a potentially life-threatening condition which often effects transplant patients
Read More
Tag: Post-steroid
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
